Vanda Pharma (VNDA) July volatility elevated at 122
Up)
Vanda Pharma (Nasdaq: VNDA) : Vanda Pharmaceuticals-VNDA closed at $13.06. VNDA announced on May 6 the FDA granted marketing approval of Fanapt for the treatment of adult schizophrenia. VNDA June option implied volatility is at 120, July is at 122, September is at 91; above its six month average of 82, according to Track Data, suggesting larger price fluctuations. Paul Foster
You May Also Be Interested In
- OmniVision (OVTI) Volatility Up on Move Lower
- DryShips (DRYS) Trading Higher on Volatility, New Analyst Coverage
- Stocks with Implied Volatility Below IV Index Mean; JCP GMCR
Create E-mail Alert Related Categories
OptionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
